Arena Pharmaceuticals, Inc. Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent
Arena Pharmaceuticals, Inc. had Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent of $3.48 million as of 2019-09-30, per its 10-Q filed 2019-11-08.
Discontinued › Balance Sheet › Assets › Assets, Noncurrent
us-gaap:ContractWithCustomerAssetNetNoncurrent · last filed 2019-11-08
- 2019-09-30: Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent $3.48M.
- 2019-06-30: Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent $3.78M.
- 2019-03-31: Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent $4.14M.
- 2018-12-31: Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent $4.47M.
| Period end | Contract with Customer, Asset, after Allowance for Credit Loss, Noncurrent |
|---|---|
| 2019-09-30 | $3.48M 10-Q · filed 2019-11-08 |
| 2019-06-30 | $3.78M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $4.14M 10-Q · filed 2019-05-09 |
| 2018-12-31 | $4.47M 10-Q · filed 2019-11-08 |
| 2018-09-30 | $4.25M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $2.36M 10-Q · filed 2018-08-07 |
| 2018-03-31 | $2.69M 10-Q · filed 2018-05-09 |
| 2018-01-01 | $2.70M 10-K · filed 2019-02-28 |
| 2017-12-31 | $2.70M 10-Q · filed 2018-11-08 |